Cancer immunotherapy

Cancer immunotherapy, Artificial stimulation of the immune system to treat cancer.

Cancer immunotherapy image

Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease. It is an application of the fundamental research of cancer immunology and a growing subspeciality of oncology. Cancer immunotherapy exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g., carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.

Immunotherapy
4 months ago

Immunotherapy ... activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies. In recent years, immunotherapy has become...

Sean Parker
3 months ago

Sean Parker ... 2016, the Parker Institute for Cancer Immunotherapy scientists funded a clinical trial to test the next wave of cancer-fighting T-cells engineered using...

Cancer vaccine
4 months ago

Cancer vaccine ... other cancer vaccines. CancerVax (Canvaxin), Genitope Corp (MyVax personalized immunotherapy), and FavId FavId (Favrille Inc) are examples of cancer vaccine...

James P. Allison
4 months ago

James P. Allison ... executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas. His discoveries have led to new cancer treatments for...

Individualized cancer immunotherapy
3 months ago

Individualized cancer immunotherapy ... Individualized cancer immunotherapy, also referred to as individualized immuno-oncology, is a novel concept for therapeutic cancer vaccines that are truly...

BioNTech
3 months ago

BioNTech ... on messenger ribonucleic acid (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement...

Uğur Şahin
3 months ago

Uğur Şahin ... medicine at the University of Cologne, completing a PhD there in cancer immunotherapy. He initially remained in academia, conducting research at university...

RNA therapeutics
3 months ago

RNA therapeutics ... mRNA encoding cancer antigens by BioNTech has started with patients with melanoma (NCT01684241). Recently, the new cancer immunotherapy, the combining...

Cancer immunology
3 months ago

Cancer immunology ... development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer. Cancer immunosurveillance...

Tasuku Honjo
3 months ago

Tasuku Honjo ... this discovery significantly contributed to the establishment of cancer immunotherapy principle by PD-1 blockade. Honjo has received several awards and...

Society for Immunotherapy of Cancer
3 months ago
Dendritic cell-based cancer vaccine
3 months ago
PD-1 and PD-L1 inhibitors
2 months ago
Adenosine A2A receptor
3 months ago
Neoepitope
3 months ago
Akkermansia muciniphila
3 months ago
Pembrolizumab
3 months ago
Cancer Immunology, Immunotherapy
3 months ago
Kite Pharma
3 months ago
This article is copied from an article on Wikipedia® - the free encyclopedia created and edited by its online user community. This article is distributed under the terms of GNU Free Documentation License.